AI MARKET SCANNING

Mink Therapeutics Inc

📅 Next Catalyst: Nov 12, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -0.44%
MAX GAP RECORD -25.14%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $INKT
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 13, 2026 Earnings Release 2026-08-13 (BEFORE OPEN)
-0.62%
Mar 31, 2026 Earnings Release 2026-03-31 (AFTER CLOSE)
+11.78%
Nov 14, 2025 Earnings Release 2025-11-14 (AFTER CLOSE)
+1.18%
Aug 14, 2025 Earnings Release 2025-08-14 (BEFORE OPEN)
-25.14%
May 15, 2025 Earnings Release 2025-05-15 (BEFORE OPEN)
+6.40%
Mar 18, 2025 Earnings Release 2025-03-18 (BEFORE OPEN)
+8.22%
Nov 14, 2024 Earnings Release 2024-11-14 (BEFORE OPEN)
+0.76%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.3%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $INKT

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H. Armen in 2017 and is headquartered in New York, NY.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗